PRESS RELEASE published on 10/10/2025 at 15:44, 6 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc's ordinary shares as of 09 October 2025 Form 8.3 Irish Takeover Panel Vanguard Group Financial Disclosure Mural Oncology Plc
BRIEF published on 10/10/2025 at 15:44, 6 months 27 days ago The Vanguard Group Discloses Position in Dowlais Group plc Shares Disclosure Takeover Code Vanguard Group Dowlais Group
BRIEF published on 10/10/2025 at 15:44, 6 months 27 days ago Le groupe Vanguard révèle sa position dans Dowlais Group plc Actions Groupe Vanguard Code De Prise De Contrôle Divulgation Groupe Dowlais
PRESS RELEASE published on 10/10/2025 at 15:43, 6 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.36% stake in Greencore Group plc through Form 8.3. Details of positions and dealings provided on 10 October 2025 Form 8.3 Financial Dealings Vanguard Group Stake Disclosure Greencore Group Plc
BRIEF published on 10/10/2025 at 15:43, 6 months 27 days ago The Vanguard Group's Position on Empiric Student Property The Vanguard Group Securities Disclosure Shareholding UK Takeover Code Empiric Student Property
BRIEF published on 10/10/2025 at 15:43, 6 months 27 days ago La position du groupe Vanguard sur la propriété étudiante empirique Actionnariat Le Groupe Vanguard Divulgation Des Valeurs Mobilières Code Britannique Des OPA Propriété Empirique Des Étudiants
PRESS RELEASE published on 10/10/2025 at 15:42, 6 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% interest in Spire Healthcare Group plc through Form 8.3. Details of securities and transactions provided Securities Form 8.3 Disclosure Vanguard Group Spire Healthcare Group
BRIEF published on 10/10/2025 at 15:41, 6 months 27 days ago The Vanguard Group Discloses Position in Petershill Partners Takeover Code Securities Disclosure Vanguard Group Market Activity Petershill Partners
BRIEF published on 10/10/2025 at 15:41, 6 months 27 days ago Le groupe Vanguard révèle sa participation dans Petershill Partners Groupe Vanguard Code De Prise De Contrôle Activité Du Marché Divulgation Des Valeurs Mobilières Petershill Partners
PRESS RELEASE published on 10/10/2025 at 15:40, 6 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc The Vanguard Group, Inc. discloses 1.81% interest in Alphawave IP Group plc. Also making disclosures related to Qualcomm Incorporated. Details in Form 8.3 released on 10-Oct-2025 Form 8.3 Vanguard Group Disclosures Qualcomm Alphawave IP
Published on 05/07/2026 at 05:40, 2 hours 46 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 6 hours 26 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 8 hours 56 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 9 hours 21 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 9 hours 26 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/07/2026 at 08:05, 21 minutes ago Hyundai Mobis Develops Power Electric Systems Ready to All EV Models
Published on 05/07/2026 at 08:05, 21 minutes ago Nota AI Signs AI Optimization Technology Supply and Strategic Partnership Agreement with Mobilint Accelerating Commercialization of On-Device AI on Domestic NPU Infrastructure
Published on 05/07/2026 at 08:00, 26 minutes ago Financial results Q1 2026 – Strong, profitable growth
Published on 05/07/2026 at 08:00, 26 minutes ago AIXTRON supplied Planetary GaN MOCVD Systems to Renesas for High-Volume Manufacturing Expansion
Published on 05/07/2026 at 08:00, 26 minutes ago Pentixapharm Reports First Quarter 2026 Results and Highlights Clinical and Regulatory Momentum
Published on 05/06/2026 at 18:00, 14 hours 26 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 14 hours 26 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 14 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
